Literature DB >> 26411843

Updated New Zealand health system cost estimates from health events by sex, age and proximity to death: further improvements in the age of 'big data'.

Tony Blakely1, June Atkinson, Giorgi Kvizhinadze, Nhung Nghiem, Heather McLeod, Anna Davies, Nick Wilson.   

Abstract

AIMS: We aimed to: (i) update previous health system cost estimates (Blakely et al NZMJ 2014;127(1393)) using updated costing data and more refined methods; and (ii) provide context around current developments in the improved networking of health information systems in New Zealand.
METHODS: As per our previous work, national health event data were linked for hospitalisations, inpatient procedures, outpatient events, pharmaceuticals, laboratory tests, and primary care consultations for the whole country. For each health event a cost was assigned. Health expenditure by sex and age, and proximity to death (last 6 or 12 months of life), was then calculated.
RESULTS: The updated and more accurate method allocated lower amounts of total public health expenditure than the previous work: $6.1, $6.0 and $6.7 billion dollars (inflation-adjusted to 2011 NZ$) in 2007/08, 2008/09 and 2009/10 financial years, respectively. But the latter is still only 52% of total health system costs ($6.7/$12.98 billion). Health system costs for people not within six months of death were similar to the previous work, except for being reduced in the most elderly age groups (range: $495 per person-year in 10-14 year old females; to $5,239 per person-year in 85-89 year old males). Costs in the last six months of life remained highly variable by age group (by a factor of 14 and being maximal at $23,400 or more among 1-4 year olds). The proportion of cumulative health expenditure in the last year of life declined with increasing age of death: eg, 47%, 25%, 13% and 6% for individuals aged 40, 70, 80 and 90 respectively.
CONCLUSIONS: Health system costs vary markedly across the life course, and are skewed to the last year of life. This analysis has benefited from quality improvements in cost data and method refinements, but further improvements in coming years are likely. This is particularly so with access to additional data sources, and with the move towards better integration of "big data" in the New Zealand health sector.

Entities:  

Mesh:

Year:  2015        PMID: 26411843

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.

Authors:  Michelle Tew; Philip Clarke; Karin Thursky; Kim Dalziel
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

2.  Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries.

Authors:  Hamraz Mokri; Ingelin Kvamme; Linda de Vries; Matthijs Versteegh; Pieter van Baal
Journal:  Eur J Health Econ       Date:  2022-08-04

3.  Home modification to reduce falls at a health district level: Modeling health gain, health inequalities and health costs.

Authors:  Nick Wilson; Giorgi Kvizhinadze; Frank Pega; Nisha Nair; Tony Blakely
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

4.  The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.

Authors:  Nhung Nghiem; Tony Blakely; Linda J Cobiac; Christine L Cleghorn; Nick Wilson
Journal:  BMC Public Health       Date:  2016-05-23       Impact factor: 3.295

5.  Modeling health gains and cost savings for ten dietary salt reduction targets.

Authors:  Nick Wilson; Nhung Nghiem; Helen Eyles; Cliona Ni Mhurchu; Emma Shields; Linda J Cobiac; Christine L Cleghorn; Tony Blakely
Journal:  Nutr J       Date:  2016-04-26       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.